The Taiwan FDA (TFDA) reviews a New Drug Application (NDA) by evaluating clinical, manufacturing, and quality data to ensure the drug’s safety, efficacy, and quality. The review process involves technical assessments, Good Manufacturing Practices (GMP) verification, and may include consultations or requests for additional information. Priority drugs may receive accelerated reviews.